Nexalin Technology entered into a definitive exclusive distribution agreement with Inovanexa Medical Technologies for its Nexalin Sync neurostimulation device across Brazil, Argentina, Chile, Uruguay, Paraguay, Ecuador and Venezuela. The ten-year deal includes an initial 100-device commercialization program, requiring a binding purchase order of five devices immediately and five more within twelve months to support a clinical pilot in Brazil launching within 90 days. Exclusivity is contingent on minimum revenue thresholds over the first 30 months and annually thereafter. Upon purchasing the first 30 devices, the distributor must establish a local manufacturing facility in Brazil at its own cost, generating recurring per-device compensation and disposable royalties for Nexalin. The company operates in the medical technology industry, developing non-invasive neurostimulation devices for mental health treatment.
